The use of transvaginal ultrasound and saline infusion sonohysterography for the evaluation of asymptomatic postmenopausal breast cancer patients on tamoxifen

Ultrasound in Obstetrics and Gynecology

Volumn 11, Issue 1, 1998, Pages 48-53

  Schwartz, L B ^a   Snyder, J ^a   Horan, C ^a   Porges, R F ^a   Nachtigall, L E ^a   Goldstein, S R ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Antiestrogens; Breast cancer; Endometrial cancer; Endometrial polyps; Endometrial thickness; Endovaginal ultrasound; Postmenopausal; Sonohysterography; Tamoxifen; Transvaginal ultrasound

Indexed keywords

SODIUM CHLORIDE; TAMOXIFEN;

ARTICLE; BREAST CANCER; CANCER RECURRENCE; CLINICAL ARTICLE; CONTROLLED STUDY; CURETTAGE; ENDOMETRIUM BIOPSY; ENDOMETRIUM CANCER; ENDOMETRIUM TUMOR; FEMALE; HUMAN; HUMAN TISSUE; HYSTEROGRAPHY; PATIENT MONITORING; PATIENT REFERRAL; POSTMENOPAUSE; PRIORITY JOURNAL; TRANSVAGINAL ECHOGRAPHY;

AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; COHORT STUDIES; DILATATION AND CURETTAGE; ENDOMETRIAL NEOPLASMS; ESTROGEN ANTAGONISTS; FEMALE; HUMANS; HYSTEROSCOPY; MIDDLE AGED; POSTMENOPAUSE; RISK FACTORS; SODIUM CHLORIDE; STATISTICS, NONPARAMETRIC; TAMOXIFEN;

EID: 0031907242     PISSN: 09607692     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1469-0705.1998.11010048.x     Document Type: Article

References (28)

1. Early Breast Cancer Trials Collaborative Group. Effects of tamoxifen and of cytotoxic therapy on mortality in early breast cancer: an overview of 61 randomized trials among 28,896 women. N Engl J Med 1988;319:1681-92
2. Grenman SE, Roberts JA, England BG, Gronroos M, Carey TE. In vitro growth regulation of endometrial carcinoma cells by tamoxifen and medroxyprogesterone acetate. Gynecol Oncol 1988;30: 239-50
3. Gottardia MM, Robinson SP, Satyaswaroop PG, Jordan VC. Contrasting actions of tamoxifen on endometrial and breast tumor growth in the athymic mouse. Cancer Res 1988;48: 812-15
4. Hardell L. Tamoxifen as risk factor for carcinoma of corpus uteri [Letter]. Lancet 1988;2:563
5. Hardell L. Pelvic irradiation and tamoxifen as risk factors for carcinoma of corpus uteri [Letter]. Lancet 1989;1:875
6. Jordan VC. Tamoxifen and endometrial cancer [Letter]. Lancet 1989;2:117-20
7. Stewart HJ, Knight GM. Tamoxifen and the uterus and endometrium [Letter]. Lancet 1989;1:375-6
8. Neven P, De Muylder X, Van Belle Y. Tamoxifen and the uterus and endometrium [Letter]. Lancet 1989;1:365
9. Mathew A, Chabon AB, Kabakow B, Drucker M, Hirschman RJ. Endometrial carcinoma in five patients with breast cancer on tamoxifen therapy. NY J Med 1990;90:207-8
10. Atlanta G, Pozzi M, Vincenzoni C, Vocaturo G. Four case reports presenting new acquisitions on the association between breast and endometrial carcinoma. Gynecol Oncol 1990;37:378-80
11. Fornander T, Rutqvist LE, Cedermark B, Glas U, Mattsson A, Silfversward C, Skoog L, Somell A, Theve T, Wilking N. Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers. Lancet 1989;1:117-20
12. Neven P, De Muylder X, Van Belle Y, Vanderick G, De Mulder E. Hysteroscopic follow-up during tamoxifen treatment. Eur J Obstet Gynecol Reprod Biol 1990;35:235-8
13. Gal D, Kopel S, Bashevkin M, Lebowicz J, Lev R, Tancer ML. Oncogenic potential of tamoxifen on endometria of postmenopausal women with breast cancer - preliminary report. Gynecol Oncol 1991;42: 120-3
14. Gusberg SB. Tamoxifen for breast cancer: associated endometrial cancer [Editorial]. Cancer 1990;65:1463-4
15. Timor-Tritsch IE, Rottem S. Transvaginal Sonography, 2nd edn. New York: Elsevier, 1991:80-1
16. Nasri MN, Shephard JH, Setchell ME, Lowe DG, Chard T. The role of vaginal scan in measurement of endometrial thickness in postmenopausal women. Br J Obstet Gynaecol 1991; 98:470-5
17. Osmers R, Volksen M, Schauer A. Vaginosonography for early detection of endometrial carcinoma? Lancet 1990;335: 1569-71
18. Goldstein SR, Nachtigall M, Snyder JR, Nachtigall L. Endometrial assessment by vaginal ultrasonography before endometrial sampling in patients with postmenopausal bleeding. Am J Obstet Gynecol 1990;163:119-23
19. Cohen I, Rosen D, Tepper R, Cordoba M, Shapira Y, Altaras MM, Yigael D, Beyth Y. Ultrasonographic evaluation of the endometrium and correlation with endometrial sampling in postmenopausal patients treated with tamoxifen. J Ultrasound Med 1993;5:275-80
20. Kedar R, Bourne TH, Powles TJ, Collins WP, Ashley SE, Cosgrove DO, Campbell S. Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial. Lancet 1994;343:1318-21
21. Goldstein SR. Unusual ultrasonographic appearance of the uterus in patients receiving tamoxifen. Am J Obstet Gynecol 1994;170:447-51
22. Fisher B, Constantino JP, Redmond CK, Fisher ER, Wickerham DL, Cronin WM. Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. J Natl Cancer Inst 1994;86:527-37
23. Lahti E, Blanco G, Kauppila A, Apaja-Sarkkinen M, Taskinen PJ, Laatikainen T. Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen. Obstet Gynecol 1993;81:660-4
24. Goldstein SR. Use of ultrasonohysterography for triage of perimenopausal patients with unexplained uterine bleeding. Am J Obstet Gynecol 1994;170:565-70
25. Guido RS, Kanbour-Shakir A, Rulin MC, Christopherson WA. Pipelle endometrial sampling. J Reprod Med 1995;40: 553-5
26. ACOG Committee Opinion. Tamoxifen and Endometrial Cancer. Washington: Committee on Gynecologic Practice, 169
27. De Muylder X, Neven P, Somer M, Van Belle Y, Vanderick G, De Muylder E. Endometrial lesions in patients undergoing tamoxifen therapy, Int J Gynecol Obstet 1991;36:127-30
28. Ismail SM. Pathology of endometrium treated with tamoxifen. J Clin Pathol 1994;47:827-33